Caroline Kamali

Artiklar

Article: ESMO OPEN. 2023;8(6):102069

Validation of the ALK-Brain Prognostic Index for patients with ALK-rearranged lung cancer and brain metastases.

Zerdes I; Kamali C; Koulouris A; Elsayed M; Schnorbach J; Christopoulos P; Tsakonas G
Article: MOLECULAR ONCOLOGY. 2021;15(11):2941-2957

Multiplex immune protein profiling of fine-needle aspirates from patients with non-small-cell lung cancer reveals signatures associated with PD-L1 expression and tumor stage.

Franzén B; Viktorsson K; Kamali C; Darai-Ramqvist E; Grozman V; Arapi V; Hååg P; Kaminskyy VO; Hydbring P; Kanter L; Nyrén S; Ekman S; De Petris L; Lewensohn R
Article: CANCERS. 2021;13(4):922

Detection of Tumor-Associated Membrane Receptors on Extracellular Vesicles from Non-Small Cell Lung Cancer Patients via Immuno-PCR.

Stiller C; Viktorsson K; Paz Gomero E; Hååg P; Arapi V; Kaminskyy VO; Kamali C; De Petris L; Ekman S; Lewensohn R; Karlström AE
Article: CANCERS. 2020;12(7):E1804-1804

ALK-Brain Prognostic Index-Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain Metastases.

Tsakonas G; Kamali C; De Petris L; Friesland S; Lewensohn R; Ekman S